Artificial Intelligence in Dental Diagnostics: From Caries Detection to Treatment Planning

Artificial intelligence (AI) is reshaping the landscape of dental diagnostics at a pace that few could have predicted a decade ago. Deep learning algorithms, particularly convolutional neural networks (CNNs) optimized for image analysis, have demonstrated diagnostic accuracy comparable to or exceeding that of experienced clinicians across a growing range of tasks: caries detection on bitewing radiographs, periapical lesion identification, cephalometric landmark detection, periodontal bone loss quantification, and oral cancer screening. The integration of AI into dental practice raises fundamental questions about the role of the clinician, the structure of diagnostic workflows, and the medicolegal implications of algorithm-assisted decision-making. This article reviews the current state of AI in dental diagnostics, the underlying technologies, validation challenges, and the pathways toward clinical implementation.

Foundations: Machine Learning in Dental Imaging

Modern AI in dental diagnostics is built almost exclusively on deep learning, a subset of machine learning in which artificial neural networks with many layers ("deep" architectures) learn hierarchical representations directly from raw data. The breakthrough that enabled current applications was the development of convolutional neural networks (CNNs) specifically designed for image analysis. CNNs learn to detect low-level features (edges, textures, color gradients) in early layers and progressively assemble these into higher-level representations (shapes, objects, patterns) in deeper layers.

The key innovation is that CNNs learn these features from data rather than relying on hand-crafted feature detectors programmed by human engineers. A CNN trained on a sufficiently large dataset of labeled radiographs can learn to recognize the radiographic appearance of caries without a programmer explicitly encoding rules about radiolucency, lesion location, or shape characteristics. This data-driven approach has advantages (the algorithm can detect patterns the human programmer might not think to encode) and disadvantages (the algorithm's decision-making process is opaque, creating the "black box" problem).

Most current dental AI applications use supervised learning: the network is trained on a dataset where each image is labeled with the correct diagnosis (caries present/absent, lesion type, landmark coordinates). The network adjusts its internal parameters through iterative optimization to minimize the difference between its predictions and the ground-truth labels. The quality of the training data—its size, diversity, annotation accuracy, and freedom from bias—is the single most important determinant of AI performance.

Caries Detection

Caries detection on bitewing radiographs is the most studied and commercially mature dental AI application. Multiple commercial systems are now available (Pearl's Second Opinion, Denti.AI, Overjet, VideaHealth) that analyze bitewing and periapical radiographs to detect and outline carious lesions, quantify lesion depth, and flag lesions that may have been overlooked by the clinician.

Meta-analyses of AI caries detection on bitewing radiographs report sensitivity of 80-90% and specificity of 85-95%, with area under the receiver operating characteristic curve (AUC) values of 0.90-0.96. These figures compare favorably with general dental practitioners, whose sensitivity for proximal caries detection on bitewings is approximately 50-60% at the enamel lesion level. The AI advantage is most pronounced for enamel lesions confined to the outer half of enamel, which are clinically significant (remineralization is possible without restoration) but commonly missed on visual radiographic interpretation.

The clinical workflow for AI-assisted caries detection is straightforward. The AI system integrates with the practice management or imaging software. When a bitewing radiograph is acquired, it is automatically analyzed by the AI system, which returns annotated images with lesions outlined and color-coded by depth within seconds. The clinician reviews the AI annotations alongside the original radiograph and makes the final diagnostic and treatment decision. This "AI as second reader" model preserves clinical autonomy while providing a safety net for missed lesions.

Several studies have documented that AI assistance improves clinician caries detection performance. General dentists shown AI-annotated radiographs detected approximately 15-25% more carious lesions than when interpreting the same radiographs unassisted, without a significant increase in false-positive diagnoses. The improvement was greatest for less experienced clinicians, suggesting that AI may help narrow the diagnostic performance gap between novices and experts.

Periapical Pathology and Endodontic Applications

AI detection of periapical radiolucencies on periapical radiographs and CBCT scans has advanced rapidly. CNNs can detect periapical lesions with sensitivity of 85-95% and specificity of 88-97% on periapical radiographs. Performance on CBCT is superior because the three-dimensional data eliminates the superimposition that obscures periapical pathology on two-dimensional radiographs.

Beyond simple detection, AI systems can perform differential diagnosis between periapical granulomas and radicular cysts—a distinction with therapeutic implications (cysts are less likely to resolve with conventional root canal treatment). Studies using CNNs trained on histopathologically confirmed lesions report accuracy of 80-90% in differentiating these entities on CBCT, though independent validation in diverse populations is limited.

In endodontic treatment planning, AI applications include: working length determination (CNN analysis of preoperative radiographs to predict canal length); root canal morphology classification (detection of MB2 canals in maxillary molars, identification of C-shaped canals); and vertical root fracture detection (CNN analysis of CBCT with reported sensitivity of 85-95%, a task considered challenging even for experienced endodontists). These applications remain primarily in the research domain, with few commercially available products.

Cephalometric Analysis and Orthodontic Applications

Automated cephalometric landmark detection has been a focus of dental AI research for decades, predating the deep learning era. Earlier approaches using edge detection, active shape models, and knowledge-based systems achieved landmark identification accuracy of 2-4 mm error per landmark, which is clinically unacceptable for treatment planning. Deep learning has transformed this field: modern CNN-based systems achieve mean landmark identification errors of 1.0-1.5 mm, within or approaching the 1.0-2.0 mm range considered clinically acceptable.

Commercial AI cephalometric analysis systems (CephX, WebCeph, DentaliQ.Ortho) are now widely used in orthodontic practices. The workflow is: upload a lateral cephalometric radiograph → AI automatically identifies 20-80+ landmarks → generates a cephalometric tracing with standard analyses (Steiner, McNamara, Ricketts, etc.) → clinician reviews and adjusts landmark positions as needed → approved analysis is used for treatment planning. The time savings are substantial: manual cephalometric tracing typically requires 15-20 minutes per case, while AI analysis completes in under 30 seconds.

Orthodontic applications extend beyond cephalometrics. AI systems can predict extraction vs. non-extraction treatment decisions, forecast treatment duration, assess cervical vertebral maturation for growth prediction, and simulate soft tissue profile changes after orthognathic surgery. These predictive applications are less mature than diagnostic ones and should be interpreted as decision support tools, not definitive treatment recommendations.

Oral and Maxillofacial Pathology Screening

AI-assisted screening for oral potentially malignant disorders (OPMDs) and oral squamous cell carcinoma (OSCC) has attracted intense research interest because early detection dramatically improves prognosis (5-year survival for localized OSCC is ~85% vs. ~40% for metastatic disease). The challenge is that early oral cancers and OPMDs can be subtle, heterogeneous in appearance, and easily confused with benign lesions.

Photographic AI screening uses CNNs trained on clinical photographs of oral lesions to classify images as suspicious or non-suspicious. Studies report sensitivity of 85-95% and specificity of 80-90% for detection of OSCC and high-grade dysplasia, though most studies use datasets from single institutions with limited diversity. Fluorescence visualization devices (VELscope, Identafi) and autofluorescence imaging combined with AI classification are also under investigation.

Cytology-based AI screening is a complementary approach. Liquid-based cytology samples collected by brush biopsy can be analyzed by AI systems trained to detect abnormal keratinocytes. This approach combines minimally invasive sampling with automated analysis, potentially enabling screening by non-specialist providers. Several commercial systems are in development but none have achieved regulatory approval in major markets as of 2025.

Periodontal Assessment

AI-assisted periodontal assessment addresses two problems: the time-consuming nature of full-mouth periodontal charting and the variability in radiographic interpretation of bone loss. AI systems analyzing bitewing and periapical radiographs can automatically segment teeth, identify the cemento-enamel junction (CEJ) and alveolar bone crest, and calculate bone loss as a percentage of root length. Accuracy of automated bone loss measurement is within 5-10% of manual measurements by periodontists, with high reproducibility (unlike humans, the AI gives the same result every time it analyzes the same radiograph).

Integration of radiographic AI with clinical data (probing depths, bleeding on probing, mobility, furcation involvement) to generate automated periodontal diagnoses and treatment plans is an active area of research. The 2017 World Workshop classification of periodontal diseases, which requires staging and grading based on multiple parameters, is well-suited to AI decision support that can systematically integrate disparate data points into a standardized classification.

Regulatory, Ethical, and Medico-Legal Considerations

The regulatory landscape for dental AI is evolving rapidly. The U.S. Food and Drug Administration (FDA) has cleared multiple dental AI systems through the 510(k) pathway as Class II medical devices, including systems for caries detection, periapical lesion detection, and cephalometric analysis. The European Union Medical Device Regulation (EU MDR) imposes more stringent requirements, including clinical evidence requirements and post-market surveillance obligations that may slow adoption in European markets.

Medico-legal questions remain largely unresolved. If an AI system fails to detect a carious lesion that a reasonably competent dentist would have identified, and the lesion progresses to require endodontic treatment or extraction, who bears the liability? The current consensus—reflected in FDA labeling that characterizes AI as a "clinical decision support tool" requiring clinician interpretation—places ultimate responsibility on the clinician. However, as AI systems approach and exceed human diagnostic performance, this allocation of responsibility may shift.

Algorithmic bias is a critical concern. If an AI system is trained predominantly on radiographs from one demographic group, it may perform less accurately on patients from other groups—a form of bias that could exacerbate existing healthcare disparities. Ensuring diverse, representative training data and validating AI systems across multiple demographic groups and clinical settings is an ethical imperative that the dental AI industry has only begun to address systematically.

Conclusion

AI in dental diagnostics has moved from proof-of-concept to commercial reality, with systems for caries detection, periapical lesion identification, and cephalometric analysis already in routine clinical use. The evidence supports AI as an effective second reader that improves diagnostic accuracy, particularly for less experienced clinicians and for subtle lesions. However, AI remains a tool, not a replacement for clinical judgment. The clinician's role in integrating AI outputs with clinical examination findings, patient history, and individual treatment preferences remains essential. The next frontier—predictive AI that forecasts treatment outcomes, disease progression, and optimal treatment pathways—promises to further transform the diagnostic landscape, though these applications require substantially more validation before routine clinical deployment.